Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy

Am J Med Genet. 2001 Oct 15;103(3):241-4.

Abstract

Hypertension in pregnancy (HP), including preeclampsia, is known to be a multifactorial disease. Recently, a Glu298Asp variant of the endothelial nitric oxide synthase gene (NOS3) was identified as being associated with coronary spasm and myocardial infarction, whereas it has been reported that endothelial nitric oxide synthase plays a role in HP. We therefore performed an association study of the Glu298Asp variant with HP among 152 HP patients and 335 normal pregnant control individuals, in the context of other risk factors before pregnancy. The frequency of the variant GA+AA NOS3 genotypes was significantly higher in the patients (0.23) than in the controls (0.12) (P < 0.01). Multivariate analysis revealed that family history of hypertension, TT genotype of the angiotensinogen gene (AGT), GA+AA NOS3 genotype, and prepregnancy body mass index > or = 24 were independent potent risk factors, after adjustment for maternal age and parity. The odds ratios of the factors were 2.7, 2.3, 2.2, and 2.1, respectively. Our results suggested that the Asp298 of NOS3 is a potent, independent risk factor for HP.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensinogen / genetics
  • Body Mass Index
  • Female
  • Genetic Variation
  • Genotype
  • Humans
  • Hypertension / genetics*
  • Maternal Age
  • Multivariate Analysis
  • Nitric Oxide Synthase / genetics*
  • Nitric Oxide Synthase Type III
  • Parity
  • Pedigree
  • Pre-Eclampsia / genetics*
  • Pregnancy
  • Risk Factors

Substances

  • Angiotensinogen
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III